Why the study?
Do calcium antagonists reduce perioperative cardiovascular complications in patients undergoing cardiac surgery and angioplasty?
Do calcium antagonists reduce perioperative cardiovascular complications in patients undergoing cardiac surgery and angioplasty?
Calcium antagonists have a significant evidence base for reducing perioperative ischemic complications and restenosis in patients undergoing cardiac surgery and angioplasty, despite some safety signals like increased bleeding with nimodipine.
Answers are grounded in this paper and cite their sources.
May support calcium antagonists perioperatively in cardiac surgery; leaves open confirmation in RCTs and role in angioplasty.
Results of randomized clinical trials on the usage of calcium antagonists (CA) in order to prevent perioperative complications during aortocoronary bypass procedure and operations on heart valves are analyzed. CA reduced the risk of perioperative myocardial infarctions and episodes of reversible myocardial ischemia. After angioplasty of coronary arteries CA (particularly amlodipine) show positive effects on restenosis incidence and reduce about 3 times a number of repeated angioplasty and aortocoronary bypass operations. The use of CA was accompanied by more often need in heart electro stimulation without any subclass differences. It is also registered that nimodipine can strengthen intraoperative blood loss. It is concluded, that CA have significant evident base that allows recommending them to patients undertaken by cardiological surgery.
No takes yet. Share an insight, caveat, or question.
С. В. Недогода (2006) conducted a review in Cardiac surgery. Calcium antagonists was evaluated on Perioperative complications.
Synapse has enriched 10 related papers. Consider them for comparative context: